SCHEMBL8679794

SCHEMBL8679794

CCc1ccc(COc2ccc(C(=O)NC(CCOc3ccccc3)C(=O)O)c(C)c2C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.43
FNTA P49354 1/20 0.42
FNTB P49356 1/20 0.42
MAPT P10636 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
KDM4E B2RXH2 1/20 0.40
GPR132 Q9UNW8 1/20 0.40
LMNA P02545 1/20 0.40
CTSL P07711 1/20 0.40
CTSS P25774 1/20 0.40
GRM2 Q14416 1/20 0.39
MME P08473 1/20 0.39
ACE P12821 1/20 0.39
CPA1 P15085 1/20 0.39
ACE2 Q9BYF1 1/20 0.39
ICMT O60725 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8676560 0.92 FNTA (0.41) FNTAFNTBMAPTL3MBTL1CYP2C9
SCHEMBL8679534 0.91 PTPN1 (0.46) PPARGFNTAFNTBMAPTL3MBTL1
SCHEMBL8678019 0.90 PPARG (0.45) PPARGFNTAFNTBMAPTL3MBTL1
SCHEMBL8677140 0.90 SRD5A2 (0.45) PPARGFNTAFNTBMAPTL3MBTL1
SCHEMBL8676384 0.87 GPR132 (0.43) FNTAFNTBGPR132
SCHEMBL8676266 0.86 FNTA (0.38) FNTAFNTBMAPTL3MBTL1CYP2C9
SCHEMBL8675834 0.85 FNTA (0.41) PPARGFNTAFNTBL3MBTL1TDP1
SCHEMBL8679817 0.85 GRM2 (0.43) PPARGGPR132GRM2
SCHEMBL8678028 0.84 GRM2 (0.45) PPARGGPR132GRM2
SCHEMBL8678794 0.83 GRM2 (0.47) PPARGGPR132GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5753641-A SYNERGISTIC THERAPY COMPRISING FINASTERIDE AND TERAZOSIN DRUGS MERCK & CO., INC. (US) 1998-05-19 US disclosed